IPP Bureau
Dr Reddys Laboratories signs for consumption of renewable energy
By IPP Bureau - July 18, 2023
Lonza launches new cell culture media system TheraPRO
By IPP Bureau - July 18, 2023
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
PredOmix, Core Diagnostics partner to launch OncoVeryx-F
By IPP Bureau - July 18, 2023
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
JeNaCell launches wound dressing epicite balance for chronic wounds
By IPP Bureau - July 17, 2023
Moist wound dressing for chronic wound treatment now available in Germany
Evonik and Heraeus cooperate to expand the range of services for highly potent API
By IPP Bureau - July 17, 2023
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
CARER collaborates with Wholeleaf to enhance holistic cancer care services
By IPP Bureau - July 17, 2023
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Lupin receives approval from USFDA for Chlorpromazine Hydrochloride Tablets USP
By IPP Bureau - July 14, 2023
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
Granules India announces approval for Acetaminophen and Ibuprofen Tablets
By IPP Bureau - July 14, 2023
This product will be launched through Granules Consumer Health (GCH) division
Singapore hosts start-up immersion programme for Indian MBBS doctors
By IPP Bureau - July 11, 2023
The programme was conducted as a part of MPMCx, an exclusive management programme for MBBS doctors by IIM-Ahmedabad in collaboration with DailyRounds
Briefs: Link Pharma Chem and Zydus
By IPP Bureau - July 11, 2023
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Bausch + Lomb acquires Blink eye drops
By IPP Bureau - July 11, 2023
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
NMPA approval for first BCMA CAR-T Therapy paves way for more multiple myeloma cell therapies, says GlobalData
By IPP Bureau - July 11, 2023
Approval to dramatically change CAR-T therapies landscape
Sumitomo Pharma America launches as new combined organization
By IPP Bureau - July 11, 2023
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
